13.01
9.65%
-1.39
Handel nachbörslich:
13.09
0.08
+0.61%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Finanzdaten der Novavax, Inc.-Aktie (NVAX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
55.81%
291.34
|
186.99 | 424.43 | 80.95 | 357.40 |
Cost Of Revenue |
56.65%
154.98
|
98.93 | 55.78 | 34.09 | 181.76 |
Gross Profit |
54.86%
136.37
|
88.06 | 368.65 | 46.87 | 175.63 |
Operating Expenses
|
49.72%
319.93
|
213.69 | 313.19 | 359.63 | 419.51 |
Interest Income/Expense |
44.00%
4.117
|
2.859 | 3.124 | 4.316 | 4.601 |
Benefits Costs and Expenses |
46.97%
468.04
|
318.46 | 366.56 | 373.67 | 541.91 |
Costs And Expenses |
51.91%
474.91
|
312.62 | 368.97 | 393.72 | 601.28 |
Depreciation and Amortization |
4.66%
10.79
|
11.32 | 10.07 | 9.043 | 7.222 |
Operating Income/Loss |
46.12%
-183.57
|
-125.63 | 55.46 | -312.77 | -243.88 |
Income/Loss From Continuing Operations Before Tax |
34.40%
-176.70
|
-131.47 | 57.87 | -292.72 | -184.51 |
Income Tax Expense/Benefit |
342.18%
1.688
|
-0.697 | -0.143 | 1.183 | -2.26 |
Income/Loss From Continuing Operations After Tax |
36.41%
-178.39
|
-130.78 | 58.01 | -293.90 | -182.25 |
Net Income/Loss
|
36.41%
-178.39
|
-130.78 | 58.01 | -293.90 | -182.25 |
Preferred Stock Dividends And Other Adjustments |
-0.027
|
- | - | -0.005 | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
92.53%
7.722
|
103.43 | 89.36 | 86.16 | 0.552 |
Diluted Average Shares |
92.53%
7.722
|
103.43 | 104.06 | 86.16 | - |
Basic Earnings Per Share |
16.67%
-1.47
|
-1.26 | 0.65 | -3.41 | -2.29 |
Diluted Earnings Per Share |
16.67%
-1.47
|
-1.26 | 0.58 | -3.41 | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-0.027
|
- | - | -0.005 | - |
Kapitalisierung:
|
Volumen (24h):